The q-PCR reagents market encompasses diverse detection types, including dye-based reagents, which use fluorescent dyes to identify DNA amplification, and probe-based reagents, employing specific probes for precise target detection. These reagents support various assay types, such as q-PCR singleplex tests/assays, focusing on one target per reaction, and q-PCR multiplex tests/assays, allowing simultaneous analysis of multiple targets. These options cater to the needs of healthcare and research professionals, offering flexibility and accuracy in diagnostic and analytical applications.
Access Full Report at @ https://www.databridgemarketresearch.com/reports/europe-q-pcr-reagents-market
Data Bridge Market Research analyses that the Europe q-PCR Reagents Market was valued at USD 303.03 million in 2021 and is expected to reach the value of USD 465.07 million by 2029, at a CAGR of 5.5% during the forecast period 2022-2029. The driver for the q-PCR reagents market is the heightened utilization in agricultural and food safety testing. q-PCR reagents offer rapid and accurate analysis, ensuring the safety and quality of food products and addressing concerns about contaminants and pathogens in the agricultural and food industry.
Key Findings of the Study
Regulatory support is expected to drive the market's growth rate
Stringent regulatory standards and guidelines are pivotal drivers in the q-PCR Reagents Market. These regulations compel healthcare and diagnostic entities to ensure adherence to rigorous quality control and compliance measures. q-PCR reagents are crucial in meeting these standards by providing precise and reliable molecular diagnostic results. As a result, the market experiences increased demand, as healthcare providers and researchers rely on q-PCR reagents to maintain high-quality diagnostic practices and meet the stringent requirements imposed by regulatory authorities.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014-2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Detection Type (Dye-Based Reagents and Probe-Based Reagents), Assay Type (q-PCR Singleplex Test/Assay and q-PCR Multiplex Test/Assay), Plexity (Dye-Based Reagents, and Probe-Based Reagents), Packaging Type (Kits, and Master Mixers), Technology (Gene Expression, Gene Typing, MIRNA Analysis, Pre-Amplification, and Virus Detection), Application (Research, Diagnostics, and Forensic), End-User (Research and Academic Institute, Hospitals, Clinical Research Organization, Forensic Laboratories, and Others), Distribution Channel (Direct Tender, Third Party Distributors, and Others)
|
|
Countries Covered
|
Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.
|
|
Market Players Covered
|
Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Biotium (U.S.), MiRXES Pte Ltd (Singapore), GeneDireX, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Norgen Biotek Corp (Canada), Takara Holdings Inc. (Japan), Enzo Biochem Inc (U.S.), Qiagen (Germany), PCR Biosystems (U.K.), Quantabio (U.S.), Merck KGaA (Germany), Kaneka Eurogentec S.A (Belgium), Promega Corporation (U.S.), Solis BioDyne (Estonia), Seegene Inc. (South Korea), Sino Biological Inc (China), Thermo Fisher Scientific Inc (U.S.), New England Biolabs (U.S.), YouSeq Ltd (U.K.), Bioneer Corporation (South Korea)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The Europe q-PCR reagents market is categorized based on detection type, assay type, plexity, packaging type, application, technology, end user and distribution channel.
- On the basis of detection type, the Europe q-PCR reagents market is classified into dye-based reagents and probe-based reagents.
- On the basis of assay type, the Europe q-PCR reagents market is classified into q-PCR singleplex test/assay and q-PCR multiplex test/assay.
- On the basis of plexity, the Europe q-PCR reagents market is classified into dye-based reagents and probe-based reagents.
- On the basis of packaging type, the Europe q-PCR reagents market is classified into kits and master mixes.
- On the basis of technology, the Europe q-PCR reagents market is classified into gene expression, gene typing, MIRNA analysis, pre-amplification, and virus detection.
- On the basis of application, the Europe q-PCR reagents market is segmented into diagnostics, research, and forensics.
- On the basis of end user, the Europe q-PCR reagents market is segmented into hospital and diagnostic centers, forensic laboratories, research and academic institute, clinical research organization, and others.
- On the basis of distribution channel, the Europe q-PCR reagents market is segmented into direct tender, third-party distributors, and others.
Major Players
Data Bridge Market Research recognizes the following companies as the Europe q-PCR reagents market players in Europe q-PCR reagents market are Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Biotium (U.S.), MiRXES Pte Ltd (Singapore), GeneDireX, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Norgen Biotek Corp (Canada), Takara Holdings Inc. (Japan), Enzo Biochem Inc (U.S.).
Market Developments
- In November 2022, PCR Biosystems introduced an innovative family of qPCR reagent mixes known as the Clara family. This new range includes Clara Probe Mix, Clara Probe 1-Step Mix, and Clara HRM Mix, which leverage a novel composition to elevate performance and address the evolving needs of laboratories. These cutting-edge reagents signify a significant advancement in the qPCR reagents market, offering enhanced capabilities for molecular diagnostics and research applications.
- In September 2022, Integrated DNA Technologies unveiled the PrimeTime qPCR One-Step Master Mix, featuring an exclusive mutant enzyme. This master mix incorporates a patented blend, well-suited for viral research and gene expression studies. Notably, it is offered in a 4X concentrated formulation, eliminating the requirement for an extraction step. This innovation streamlines and enhances the efficiency of qPCR assays, making it ideal for various molecular biology applications.
Regional Analysis
Geographically, the countries covered in the Europe q-PCR reagents market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.
As per Data Bridge Market Research analysis:
Germany is the dominant region in the Europe q-PCR reagents market during the forecast period 2022-2029
Germany dominates the European q-PCR (quantitative polymerase chain reaction) reagents market, leading in both market share and revenue. This position is attributed to the significant presence of key market players within the country and an increasing incidence of communicable diseases such as HIV. Germany's robust healthcare infrastructure, research capabilities, and focus on disease diagnostics contribute to its leadership in the q-PCR reagents market, which is expected to continue during the forecast period.
For more detailed information about the Europe q-PCR reagents market report, click here – https://www.databridgemarketresearch.com/reports/europe-q-pcr-reagents-market
